miRNAs Participate in MS Pathological Processes and Its Therapeutic Response

Area of Science:

• Neuroimmunology
• Molecular Biology
• Genetics

Background:

• Multiple sclerosis (MS) is a leading autoimmune disorder of the central nervous system (CNS).
• Autoreactive lymphocyte migration across the blood-brain barrier (BBB) is a key factor in axonal demyelination in MS.
• MicroRNAs (miRNAs) are emerging as critical regulators in various autoimmune and neurological conditions.

Purpose of the Study:

• To review the role of microRNAs in the pathological processes of multiple sclerosis.
• To explore the involvement of miRNAs in peripheral inflammation, BBB disruption, and CNS lesions.
• To investigate the potential of miRNAs as biomarkers for MS severity and therapeutic response.

Main Methods:

• Comprehensive literature review of studies investigating microRNAs in multiple sclerosis.
• Analysis of research on miRNA involvement in key MS pathological pathways.
• Synthesis of findings related to miRNA expression and function in MS.

Main Results:

• MicroRNAs play significant roles in peripheral inflammation associated with MS.
• Specific miRNAs are implicated in the disruption of the blood-brain barrier integrity.
• miRNAs are involved in the development and progression of CNS lesions in MS patients.

Conclusions:

• MicroRNAs are crucial players in the pathogenesis of multiple sclerosis.
• Identifying specific microRNAs could lead to novel biomarkers for disease severity.
• MicroRNA profiling may aid in predicting patient response to existing and future therapies for MS.